Cargando…
Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance
For over four decades structural biology has been used to understand the mechanisms of disease, and structure-guided approaches have demonstrated clearly that they can contribute to many aspects of early drug discovery, both computationally and experimentally. Structure can also inform our understan...
Autores principales: | Pandurangan, Arun Prasad, Ascher, David B., Thomas, Sherine E., Blundell, Tom L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390495/ https://www.ncbi.nlm.nih.gov/pubmed/28408471 http://dx.doi.org/10.1042/BST20160422 |
Ejemplares similares
-
SDM: a server for predicting effects of mutations on protein stability
por: Pandurangan, Arun Prasad, et al.
Publicado: (2017) -
In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
por: Dasoondi, Rushikesh Singh, et al.
Publicado: (2023) -
Genomics, Computational Biology and Drug Discovery for Mycobacterial Infections: Fighting the Emergence of Resistance
por: Munir, Asma, et al.
Publicado: (2020) -
mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance
por: Pires, Douglas E. V., et al.
Publicado: (2016) -
Combating Antimicrobial Resistance in the Post-Genomic Era: Rapid Antibiotic Discovery
por: Yang, Yuehan, et al.
Publicado: (2023)